- Home
- TTEK vs ASND Comparison
TTEK vs ASND Comparison
Compare TTEK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTEK
- ASND
- Stock Information
- Founded
- TTEK 1966
- ASND 2006
- Country
- TTEK United States
- ASND Denmark
- Employees
- TTEK N/A
- ASND N/A
- Industry
- TTEK Military/Government/Technical
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- TTEK Consumer Discretionary
- ASND Health Care
- Exchange
- TTEK Nasdaq
- ASND Nasdaq
- Market Cap
- TTEK 9.4B
- ASND 10.6B
- IPO Year
- TTEK 1991
- ASND 2015
- Fundamental
- Price
- TTEK $36.59
- ASND $175.45
- Analyst Decision
- TTEK Buy
- ASND Strong Buy
- Analyst Count
- TTEK 5
- ASND 17
- Target Price
- TTEK $40.00
- ASND $222.18
- AVG Volume (30 Days)
- TTEK 1.8M
- ASND 428.9K
- Earning Date
- TTEK 07-30-2025
- ASND 09-02-2025
- Dividend Yield
- TTEK 0.71%
- ASND N/A
- EPS Growth
- TTEK N/A
- ASND N/A
- EPS
- TTEK 0.69
- ASND N/A
- Revenue
- TTEK $4,555,101,000.00
- ASND $398,509,511.00
- Revenue This Year
- TTEK $8.15
- ASND $77.19
- Revenue Next Year
- TTEK N/A
- ASND $75.84
- P/E Ratio
- TTEK $52.96
- ASND N/A
- Revenue Growth
- TTEK 10.76
- ASND 12.06
- 52 Week Low
- TTEK $27.27
- ASND $111.09
- 52 Week High
- TTEK $51.20
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- TTEK 63.27
- ASND 54.14
- Support Level
- TTEK $35.89
- ASND $168.01
- Resistance Level
- TTEK $36.90
- ASND $180.00
- Average True Range (ATR)
- TTEK 0.68
- ASND 6.12
- MACD
- TTEK -0.02
- ASND -0.28
- Stochastic Oscillator
- TTEK 79.59
- ASND 59.33
About TTEK Tetra Tech Inc.
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.